Journal
JOURNAL OF NEUROSCIENCE
Volume 42, Issue 49, Pages 9263-9277Publisher
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.0545-22.2022
Keywords
Key words; mitochondria; mitophagy; parkin; Parkinson ? s disease; POLG
Categories
Funding
- National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant [P50 NS38377]
- JPB Foundation
- National Science Foundation [2017238665]
- Foundation's Parkinson's Disease Program [M-20 14, M-2 016]
Ask authors/readers for more resources
In this study, a transgenic model was generated to examine the impact of Parkin loss on mitochondrial function in PolgAD257A/D257A mice. Surprisingly, no dopaminergic neurodegeneration or nigral-striatal neurobehavioral deficits were observed in these mice. These findings suggest a lack of synergism between Parkin loss and mitochondrial dysfunction in this mouse model of mitochondrial deficits.
Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). In this study, we generated a transgenic model by crossing germline Parkin-/- mice with PolgAD257A mice, an established model of premature aging and mitochondrial stress. We hypothesized that loss of Parkin-/- in PolgAD257A/D257A mice would exacerbate mitochondrial dysfunction, leading to loss of dopamine neurons and nigral-striatal specific neurobehavioral motor dysfunction. We found that aged Parkin-/-/PolgAD257A/D257A male and female mice exhibited severe behavioral deficits, nonspecific to the nigral-striatal pathway, with neither dopaminergic neurodegeneration nor reductions in striatal dopamine. We saw no difference in expression levels of nuclear-encoded subunits of mitochondrial markers and mitochondrial Complex I and IV activities, although we did observe substantial reductions in mitochondrial-encoded COX41I, indicating mitochondrial dysfunction as a result of PolgAD257A/D257A mtDNA mutations. Expression levels of mitophagy markers LC3I/LC3II remained unchanged between cohorts, suggesting no overt mitophagy defects. Expression levels of the parkin substrates, VDAC, NLRP3, and AIMP2 remained unchanged, suggesting no parkin dysfunction. In summary, we were unable to observe dopaminergic neurodegeneration with corresponding nigral-striatal neurobehavioral deficits, nor Parkin or mitochondrial dysfunction in Parkin-/-/PolgAD257A/D257A mice. These findings support a lack of synergism of Parkin loss on mitochondrial dysfunction in mouse models of mitochondrial deficits.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available